Cytokines

Current Problems in Dermatology

Volumn 9, Issue 1, 1997, Pages 3-30

  Sauder, D N ^a   Dytoc, M T ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ATOPIC DERMATITIS; CONTACT DERMATITIS; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOREGULATION; LEPROSY; LICHEN PLANUS; PAPILLOMATOSIS; PATHOGENESIS; PEMPHIGOID; PSORIASIS; REVIEW; SCLERODERMA; SKIN; SKIN DISEASE;

EID: 0031035484     PISSN: 10400486     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1040-0486(97)80019-1     Document Type: Review

References (283)

1. Thivolet J Nicholas JF Faure M Pathophysiology: immunological mechanisms in dermatological diseases Bos JO Skin immune system 1990 CRC Boca Raton (FL) 355 379
2. Bos JD Kapsenberg ML The skin immune system: its cellular constituents and their interactions Immunol Today 7 1986 235 240
3. Kock A Schwarz T Micksche M Cytokines and human malignant melanoma: immuno- and growth-regulatory peptides in melanoma biology Nathanson L Melanoma research: genetics, growth factors, metastases, and antigens 1991 Kluwer Academic Boston 41 66
4. McKenzie RC Sauder DN Keratinocyte cytokines and growth factors: functions in skin immunity and homeostasis Dermatol Clin 8 1990 649 661
5. Nozaki S Feliciani C Sauder DN Keratinocyte cytokines Dahl MV Advances in dermatology Vol 7 1991 Mosby-Year Book Chicago 83 101
6. McKenzie RC Sauder DN The role of keratinocyte cytokines in inflammation and immunity J Invest Dermatol 95 1990 105 107S
7. Luger TA Schwarz T Therapeutic use of cytokines in dermatology J Am Acad Dermatol 24 6 1991 915 926
8. Luger TA Schwarz T Krutmann J Kock A Urbanski A Kirnbauer R Cytokines and the skin (Review) Curr Probl Dermatol 19 1990 35 49
9. Yao Z Painter SL Fanslow WC Ulrich D Macduff BM Spriggs MK Armitage RJ Human IL-17: a novel cytokine derived from T cells J Immunol 155 12 1995 5483 5486
10. Suppl Albino AP The role of oncogenes and growth factors in progressive melanoma-genesis Pigment Cell Res 2 1992 199 218
11. DeLuca M Pellegrini G Zambruno G Marchisio PC Role of integrins in cell adhesion and polarity in normal keratinocytes and human skin pathologies (Review) J Dermatol 21 11 1994 821 828
12. a. Halaban R Growth regulation in normal and malignant melanocytes Recent Results Cancer Res 128 1993 133 150
13. b. Luger TA Kock A Kirnbauer R Schwarz T Ansel JC Keratinocyte-derived interleukin 3 (Review) Ann NY Acad Sci 548 1988 253 261
14. Oppenheim JJ Zachariae CO Mukaida N Matsushima K Properties of the novel proinflammatory supergene “intercrine” cytokine family (Review) Ann Rev Immunol 9 1991 617 648
15. Drummer R Schwarz T Cytokines as regulatory proteins in lymphoproliferative skin infiltrates Dermatol Clin 12 1994 283 294
16. Fustenberger G Krieg P Schnapke R The role of endogenous factors in skin carcinogenesis Recent Results Cancer Res 128 1993 323 337
17. Kondo S Sauder DN Epidermal cytokines in allergic contact dermatitis J Am Acad Dermatol 33 1995 786 800
18. Schwarz T Luger TA Effect of UV irradiation on epidermal cell cytokine production J Photochem Photobiol 4 1989 1 13
19. Fitch FW McKisic MD Lancki DW Gajewski TF Differential regulation of murine T lymphocyte subsets (Review) Ann Rev Immunol 11 1993 29 48
20. MacNeil IA Suda T Moore KW Mosmann TR Zlotnik A IL -10, a novel growth cofactor for mature and immature T cells J Immunol 145 12 1990 4167 4173
21. Dinarello CA The interleukin-1 family: 10 years of discovery FASEB J 8 1994 1314 1324
22. Gery I Waksman BH Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s) J Exp Med 136 1972 143 155
23. Luger TA Stadler BM Katz SI Oppenheim JJ Epidermal cell (keratinocyte)-derived thymocyte-activating factor (ETAF) J Immunol 127 4 1981 1493 1498
24. Oppenheim JJ Kovacs EJ Matsushima K There is more than one interleukin 1 Immunol Today 7 1986 45 56
25. Kupper TS Ballard DW Chua AO McGuire JS Flood PM Horowitz MC Human keratinocytes contain mRNA indistinguishable from monocyte interleukin 1α and β mRNA. Keratinocyte epidermal cell-derived thymoctye-activating factor is identical to interluekin 1 J Exp Med 164 6 1986 2095 2100
26. Dower SK Interleukin-1 Aggarwal BB Gutterman JU Human cytokines: handbook for basic and clinical research 1992 Blackwell Scientific Publications 46 80
27. Dinarello CA Interleukin-1 Rev Infect Dis 6 1984 51 95
28. Kupper TS Lee F Birchall N Clark S Dower S Interleukin-1 binds to specific receptors on human keratinocytes and induces granulocyte macrophage colony-stimulating factor mRNA and protein. A potential autocrine role for interleukin-1 in epidermis J Clin Invest 82 5 1988 1787 1792
29. Ristow HJ A major factor contributing to epidermal proliferation in inflammatory skin diseases appears to be interleukin-1 or a related protein Proc Natl Acad Sci U S A 84 1987 1940 1944
30. Sauder DN Carter CS Katz SI Oppenheim JJ Epidermal cell production of thymocyte-activating factor (ETAF) J Invest Dermatol 79 1 1982 34 39
31. Pentland AP Mahoney MG Keratinocyte prostaglandin synthesis is enhanced by IL-1 J Invest Dermatol 94 1990 43 46
32. Espinoza-Delgado I Bosco MC Musso T Gusella GL Longo DL Varesio L Interleukin-2 and human monocyte activation (Review) J Leukoc Biol 57 1 1995 13 19
33. Holcombe RF Clinical applications of the interleukins: present and future J La State Med Soc 146 1994 479 483
34. Lotze MT Interleukin-1 Aggarwal BB Gutterman JU Human cytokines: handbook for basic and clinical research 1992 Blackwell Scientific Publications Cambridge, Mass. 81 96
35. Schrader JT Clark-Lewis I Leslie KB Zilterrer HJ Interleukin-3 Aggarwal BB Gutterman JU Human cytokines: handbook for basic and clinical research 1992 Blackwell Scientific Publications Cambridge, Mass. 97 112
36. Luger TA Kock A Kirnbauer R Schwarz T Ansel JC Keratinocyte-derived interleukin 3 (Review) Ann N Y Acad Sci 548 1988 253 261
37. Luger TA Wirth U Kock A Epidermal cells synthesize a cytokine with interleukin-3-like properties J Immunol 134 1985 915 919
38. DeVries JE Interleukin-4 Aggarwall B Gutterman JU Human cytokines: handbook for basic and clinical research 1992 Blackwell Scientific Publications Cambridge, Mass. 113 129
39. Schimpl A Wecker E Replacement of T cell function by a T cell product Nature 237 1987 15 17
40. Hatake K Arai K Yokota T Interleukin-5 Aggarwal BB Gutterman JU Human cytokines: handbook for basic and clinical research 1992 Blackwell Scientific Publications Cambridge, Mass. 130 142
41. Haegeman G Content J Volckaert G Derynck R Tavernier J Fiers W Structural analysis of the sequence coding for aninducible 26-kDa protein in human fibroblasts Eur J Biochem 159 3 1986 625 632
42. Kishimoto T Taga T Yasukawa K Molecular structure and immunological function of human B cell differentiation factor (BSF-20) Webb DR Molecular basis of lymphokine action 1987 Humana Clifton (NJ) 123 136
43. Santhanan U Tatter SB Helfgott DC Genetics and function of human “β2-interferon/B-cell stimulatory factor-2/hepatocyte stimulating factor” (interleukin 6) Powanda MC Monokines and other non-lymphocytic cytokines 1987 Alan R. Liss New York 29 34
44. Ray A Tatter SB Santhanam U Helfgott DC May LT Sehgal PB Regulation of expression of interleukin-6. Molecular and clinical studies Ann N Y Acad Sci 557 1989 353 361
45. Sehgal PB Grieninger G Tosato G Regulation of expression of interleukin-6 Ann N Y Acad Sci 557 1989 353 361
46. Taga T Kishmoto T Interleukin-6 Aggarwal BB Gutterman JU Human cytokines: handbook for basic and clinical research 1992 Blackwell Scientific Publications 143 167
47. Hirano T Kishimoto T Interleukin-6 Sporn MB Roberts AB Handbook of experimental pharmacology. Vol 95. I: Peptide growth factors and their receptors 1989 Springer-Verlag Berlin 633 665
48. Kishimoto T The biology of interleukin-6 Blood 74 1990 1 10
49. Kupper TS May L Birchall N Keratinocytes produce IL-6, a cytokine which can provide a second signal in the activation of T cells [abstract] J Invest Dermatol 90 1988 578A
50. Luger TA Schwarz T Krutmann J Kirnbauer R Neuner P Kock A Interleukin-6 is produced by epidermal cells and plays an important role in the activation of human T-lymphocytes and natural killer cells Ann N Y Acad Sci 557 1989 405 414
51. Goodwin RG Namen AE Interleukin-7 Aggarwal BB Gutterman JU Human cytokines: handbook for basic and clinical research 1992 Blackwell Scientific Publications 168 180
52. Baggiolini M Walz A Kunkel SL Neutrophil-activating-peptide-1/interleukin-8, a novel cytokine that activates neutrophils J Clin Invest 84 1989 1045 1049
53. a. Schroder JM Christophers E Identification of a novel family of highly potent neutrophil chemotactic peptides in psoriatic scales J Invest Dermatol 87 1986 53 58
54. b. Schroder JM Chemotactic cytokines in the epidermis Exp Dermatol 1 1992 12 19
55. Peveri P Walz A Dewald B Baggiolini M A novel neutrophil-activating factor produced by human mononuclear phagocytes J Exp Med 167 5 1988 1547 1559
56. Schroder JM Christophers E Secretion of novel and homologous neutrophil-activating peptides by LPS-stimulated human endothelial cells J Immunol 142 1989 244 251
57. Matushima K Morishita K Yoshimura T Lavu S Kobayashi Y Lew W Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin-1 and tumor necrosis factor J Exp Med 167 6 1988 1883 1893
58. Larsen CG Anderson AO Appeella E Oppenheim JJ Matsushima K The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes Science 243 4987 1989 1464 1466
59. Zachariae COC Matsushima K Interleukin-8 Aggarwal BB Gutterman JU Human cytokines: handbook for basic and clinical research 1992 Blackwell Scientific Publications Cambridge, Mass. 181 195
60. Aggarwal BB Gutterman JU Other cytokines Aggarwal BB Gutterman JU Human cytokines: handbook for basic and clinical research 1992 Blackwell Scientific Cambridge, Mass. 418 435
61. Fiorentino DF Bond MW Mosmann TR Two types of mouse T helper cell: IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones J Exp Med 170 1989 2081 2095
62. Beissert S Ullrich SE Hosoi J Granstein RD Supernatants from UVB radiation-exposed keratinocytes inhibit Langerhans' cell presentation of tumor-associated antigens via IL-10 content J Leukoc Biol 58 2 1995 234 240
63. de Waal Malefyt R Yssel H Roncarolo MG Spits H de Vries JE Interleukin-10 (Review) Curr Opin Immunol 4 3 1992 314 320
64. Musashi M Yang YC Paul SR Clark SC Sudo T Ogawa M Direct and synergistic effects of interleukin-11 on murine hemopoiesis in culture Proc Natl Acad Sci USA 88 1991 765 769 3
65. Paul SR Bennett F Calvetti JA Kelleher K Wood CR O'Hara RM Jr Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine Proc Natl Acad Sci USA 87 1990 7512 7516 19
66. Stern AS Podlaski FJ Hulmes JD Pan YC Quinn PM Wolitzky AG Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells Proc Natl Acad Sci USA 87 1990 6808 6812
67. Wakefield PE James WD Samlaska CP Meltzer MS Tumor necrosis factor (Review) J Am Acad Dermatol 24 1991 675 685
68. Frei E Spriggs D Tumor necrosis factor: still a promising agent J Clin Oncol 72 1989 291 294
69. Van de Wiel PA Bloksma N Kuper CF Hofhuis FM Willers JM Macroscopic and microscopic early effects of tumor necrosis factor on murine Meth A sarcoma, and relation to curative activity J Pathol 157 1 1989 65 73
70. Aggarwal BB Tumor necrosis factor Aggarwal BB Gutterman JU Human cytokines: handbook for basic and clinical research 1992 Blackwell Scientific Publications 270 286
71. Detmar M Lessing U Stadler R Effects of recombinant human tumor necrosis factor-alpha on normal and transformed human keratinocytes in vitro [abstract] J Invest Dermatol 92 1989 419
72. Swope V Abdel-Malek Z Nordlund J IL-1 alpha, IL-6 and tumor necrosis factor-alpha are paracrine inhibitors of human melanocyte proliferation and melanogenesis [abstract] J Invest Dermatol 94 1990 582
73. Vermeer M Streilein JW Ultraviolet B light-induced alterations in epidermal Langerhans cells are mediated in part by tumor necrosis factor-alpha Photodermatol Photoimmunol Photomed 7 1990 258 265
74. Nicola NA Hemopoietic cell growth factors and their receptors Annu Rev Biochem 58 1989 45 77
75. Kupper TS Birchall N McGuire JS Induction of GM-CSF gene expression by interleukin-1 in human keratinocytes Clin Res 35 1987 581
76. Kupper TS Lee F Coleman D Chodakewitz J Flood P Horowitz M Keratinocyte-derived T-cell growth factor (KTGF) is identical to granulocyte macrophage colony-stimulating factor (GM-CSF) J Invest Dermatol 91 2 1988 185 188
77. Wong GG Clark SK Multiple actions of interleukin 6 within a cytokine network Immunol Today 9 1988 137 139
78. Crosier PS Jornick MB Clark SC Granulocyte macrophage colony-stimulating factor Aggarwal BB Gutterman JU Human cytokines: handbook for basic and clinical research 1992 Blackwell Scientific Publications Cambridge, Mass. 238 252
79. Clark SC Kamen R The human hematopoietic colony stimulating factors Science 236 1987 1229 1237
80. Heufler C Koch F Schuler G Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulator dendritic cells J Exp Med 167 1988 700 707
81. Gallo RL Staszewski R Sauder DN Knisely TL Granstein RD Regulation of GM-CSF and IL-3 production from the murine keratinocyte cell line PAM 212 following exposure to ultraviolet radiation J Invest Dermatol 97 2 1991 203 209
82. Nozaki S Abrams JS Pearce MK Sauder DN Augmentation of granulocyte/macrophage colony-stimulating factor expression by ultraviolet irradiation is mediated by interleukin 1 in Pam 212 keratinocytes J Invest Dermatol 97 1 1991 10 14
83. Kondo S Pastore S Fujisawa H Shivji GM McKenzie RC Dinarello CA Interleukin-1 receptor antagonist suppresses contact hypersensitivity J Invest Dermatol 105 3 1995 334 338
84. Reiners JJ Yoon HL Singh KP Role of immunosurveillance and immunostimulation in the processes of chemical carcinogenesis in murine skin Mukhtar H Skin cancer: mechanisms and human relevance 1995 CRC Boca Raton (FL) 237 254
85. Vasunia KB Baxter CS Granulocyte-macrophage colony-stimulating factor (GM-CSF) in cell proliferation in phorbol ester-treated mouse epidermis and PAM-212 epidermal keratinocytes [abstract] Proc Annu Meet Am Assoc Cancer Res 36 1995 A1076
86. Gospodarowicz D Fibroblast growth factors Aggarwal BB Gutterman JU Human cytokines: handbook for basic and clinical research 1992 Blackwell Scientific Publications 329 352
87. Burgess WH Maciag T The heparin binding (fibroblast) growth factor family of proteins Annu Rev Biochem 58 1989 575 606
88. Goldfarb M The fibroblast growth factor family Cell Growth Differ 1 1990 439 445
89. McKenzie RC Feliciani C Venner TJ Induction of melanoma growth factors in keratinocytes by UVB and interleukin-1 J Invest Dermatol 98 1992 565
90. Martins-Green M Boudreau N Bissell MJ Inflammation is responsible for the development of wound-induced tumors in chickens infected with Rous sarcoma virus Cancer Res 54 1994 4334 4341
91. Damm D Shipley G Hart C The expression and modulation of PDGF-α and PDGF-β in normal human keratinocytes Oppenheim J Molecular and cellular biology of cytokines 1990 Wiley-Liss New York 111 115
92. a. Williams LT Stimulation of paracrine and autocrine pathways of cell proliferation by platelet-derived growth factor Clin Res 36 1988 5 10
93. b. Deuel TF Kawahara RS Platelet derived growth factor Aggarwal BB Gutterman JU Human cytokines: handbook for basic and clinical research 1992 Blackwell Scientific Publications 300 328
94. Marquardt H Hunkapiller MW Hood LE Twardzik DR De Larco JE Stephenson JR Transforming growth factors produced by retrovirus-transformed rodent fibroblasts and human melanoma cells:amino acid sequence homology with epidermal growth factor Proc Natl Acad Sci USA 80 1983 4684 4688
95. Marquardt H Todaro GJ Human transforming growth factor J Biol Chem 257 1982 5220 5225
96. Massague J Transforming growth factor α: a model for membrane-anchored growth factors J Biol Chem 265 1990 21393 21396
97. Burgess AW Epidermal growth factor and transforming growth factor alpha Br Med Bull 45 1989 401 424
98. Derynck R The physiology of transforming growth factor-α Adv Cancer Res 3 1992 27 52
99. Lee DC Luekette NC Petch LA Transforming growth factor-α and role in neoplastic progression Cancer Treat Res 63 1992 233 254
100. Waterfield MD Epidermal growth factor and related molecules Lancet 1 1989 1243 1246
101. Derynck R Jarrett JA Chen EY Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells Nature 36 1985 701 705
102. Madisen L Webb NR Rose TM Marquardt H Ikeda T Twardzik D Transforming growth factor-beta 2: cDNA cloning and sequence analysis DNA 7 1 1988 1 8
103. Massague J The TGF-β family of growth and differentiation factors Cell 49 1990 437 438
104. Danielpour D Daot LL Flanders KC Roberts AB Spron MB Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) secreted by cells in culture J Cell Physiol 138 1989 79 86
105. Roberts AB Sporn MB Transforming growth factor-β Aggarwal BB Gutterman JU Human cytokines: handbook for basic and clinical research 1992 Blackwell Scientific Publications Cambridge, Mass. 399 417
106. Keller JR Mantel C Sing GK Ellingsworth LR Ruscetti SK Ruscetti FW Transforming growth factor β1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell lines J Exp Med 168 2 1988 737 750
107. Siepl C Bodmer S Frei K MacDonald HR De Martin R Hofer E The glioblastoma-derived T cell suppressor factor/transforming growth factor β2 inhibits T cell growth without affecting the interaction of interleukin 2 with its receptor Eur J Immunol 18 4 1988 593 600
108. Wahl SM Hunt DA Wong HL Dougherty S McCartney FN Wahl LM Transforming growth factor β is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation J Immunol 140 9 1988 3026 3032
109. Richmond A The pathogenic role of growth factors in melanoma Semin Dermatol 10 1991 246 255
110. Anisowicz A Bardwell L Sager R Constitutive overexpression of a growth-regulated gene in transformed Chinese hamster and human cells Proc Natl Acad Sci U S A 84 1987 7188 7192
111. Richmond A Thomas HG Melanoma growth stimulatory activity, a novel growth factor with a tissue distribution not restricted to melanoma tissue J Cell Biochem 36 1988 185 198
112. 2-terminal amino acid sequence identity with melanoma growth stimulatory activity J Exp Med 171 1990 1091 1100
113. Thomas HG Han JH Balentien E Derynck R Bordoni R Richmond A Purification and characterization of recombinant melanoma growth stimulating activity Methods Enzymol 198 1991 373 383
114. Pestka M Interferons Aggarwal BB Gutterman JU Human cytokines: handbook for basic and clinical research 1992 Blackwell Scientific Publications Cambridge, Mass. 1 16
115. Ansel JC Kaynard AH Armstrong CA Olerud J Bunnett N Payan D Skin—nervous system interactions (Review) J Invest Dermatol 106 1 1996 198 204
116. Bayliss WM On the origin from the spinal cord of the vasodilator fibers of the hind limb and on the nature of these fibers J Physiol (Lond) 26 1901 173
117. Lewis T The blood vessels of the human skin and their responses 1927 Shaw London
118. Baranink JN Kowalski ML Kaliner MA Neuropeptides in the skin Bos JD Skin immune system 1990 CRC Boca Raton (FL)
119. Piotrowski W Foreman JC On the action of substance P, somatostatin, and vasoactive intestinal peptide on rat peritoneal mast cells and in human skin Naunyn Schmiedebergs Arch Pharmacol 331 1985 364 368
120. Barnes PJ Brown MJ Dollery CT Fuller RW Heavey DJ Ind PW Histamine is released from skin by substance P but does not act as the final vasodilator in the axon reflex Br J Pharmacol 88 4 1986 741 745
121. Hokfelt T Johansson O Ljungdahl A Lundberg JM Schultzberg M Peptidergic neurons (Review) Nature 284 5756 1980 515 521
122. Pernow B Substance P Pharmacol Rev 35 1983 85 141
123. Barber RP Vaughn JE Slemmon JR Salvaterra PM Roberts E Leeman SE The origin, distribution and synaptic relationships of substance P axons in rat spinal cord J Comp Neurol 184 2 1979 331 351
124. Payan DG Levine JD Goetz EJ Modulation of immunity and hypersensitivity by sensory neuropeptides J Immunol 132 1984 1601 1604
125. Lazarus SG Boison DB Gold WM Nadel JA Inflammatory mediators, tachykinins, and enkephalinase in airways Int Arch Allergy Appl Immunol 82 1987 372 376
126. Helme RD Eglezos A Hoshing CS Substance P induces chemotaxis of neutrophils in normal and capsaicin-treated rats Immunol Arch Biol 65 1987 267 269
127. Nilsson J von Euler A Dalsgaard C-J Stimulation of connective tissue cell growth by substance P and substance K Nature 315 1985 61 63
128. Nakanishi S Substance P precursor and kininogen: their structures, gene organisations, and regulation Physiol Rev 67 1987 1117 1142
129. Burcher E Buck SH Multiple binding sites in hamster, rat and guinea-pig urinary bladder Eur J Pharmacol 128 1986 165 177
130. Joos G Pauwells R Van der Straeten M Effects of inhaled substance P and neurokinin A on the airways of normal and asthmatic subjects Thorax 42 1987 779 783
131. Hershey A Krause J Molecular characterization of a functional cDNA encoding the rat substance P receptor Science 247 1990 958 962
132. Hershey A Dykema P Krause J Organization, structure, and expression of a gene encoding the rat substance P receptor J Biol Chem 266 7 1991 4366 4374
133. Takeda Y Chou KB Takeda J Sachais BS Krause JE Molecular cloning, structural characterization and functional expression of the human substance P receptor Biochem Biophys Res Commun 179 3 1991 1232 1240
134. Krause J Takeda Y Hershey A Structure, functions, and mechanisms of substance P receptor action J Invest Dermatol 98 1992 2S 7S
135. Borson D Gruenert D Glucocorticoids induce neutral endopeptidase in transformed human tracheal epithelial cells Am J Physiol 260 1991 L83 L89
136. Fuller RW Courason TB Dixon CM Crossman DC Barnes PJ Sensory neuropeptide effects in human skin Br J Pharmacol 92 4 1987 781 788
137. Foreman JC Substance P and calcitonin gene-related peptides: effects on mast cells and in human skin Int Arch Allergy Appl Immunol 82 1987 366 371
138. + in murine contact sensitivity revealed by in vivo monoclonal antibody depletion J Immunol 144 1990 4121 4128
139. Pober JS Cotran RS Cytokines and endothelial cell biology Physiol Rev 70 1990 425 451
140. Ohmen JD Hanifin JM Nickoloff BJ Rea TH Wyzkowski R Kim J Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions J Immunol 154 4 1995 1956 1963
141. Salerno A Dieli F Sireci G Bellavia A Asherson GL Interleukin-4 is a critical cytokine in contact sensitivity Immunology 84 3 1995 404 409
142. + T-lymphocyte clones from nickel contact allergic and non-allergic individuals J Invest Dermatol 98 1 1992 59 63
143. Dieli F Asherson GL Romano GC Sireci G Gervasi F Salerno A IL-4 is essential for the systemic transfer of delayed hypersensitivity by T cell lines. Role of γ/δ cells J Immunol 152 6 1994 2698 2704
144. Polak L Immunological aspects of contact sensitivity: an experimental study Monogr Allergy 15 1980 1 62
145. Polak L Immunological aspects of contact sensitivity: an experimental study Monogr Allergy 15 1980 14 16
146. Polak L Immunological aspects of contact sensitivity: an experimental study Monogr Allergy 15 1980 25 29
147. Polak L Immunological aspects of contact sensitivity: an experimental study Monogr Allergy 15 1980 63 125
148. Back O Linn J In-vivo administration of interleukin 1 both enhances and suppresses contact sensitivity in mouse Br J Dermatol 126 1992 125 130
149. Robertson B Gahring L Newton R Daynes R In vivo administration of interleukin 1 to normal mice depresses their capacity to elicit contact hypersensitivity responses: prostaglandins are involved in this modification of immune function J Invest Dermatol 88 4 1987 380 387
150. Enk AH Katz I Early molecular events in the induction phase of contact sensitivity Proc Natl Acad Sci U S A 82 1992 1398 1402
151. Koide SL Inaba K Steinman RM Interleukin 1 enhances T dependent immune responses by amplifying the function of dendritic cells J Exp Med 165 1987 515 530
152. Mullarkey MF Leiferman KM Peters MS Caro I Roux ER Hanna RK Human cutaneous allergic late-phase response is inhibited by soluble IL-1 receptor J Immunol 152 4 1994 2033 2041
153. Ferretti M Casini-Raggi V Pizarro TT Eisenberg SP Nast CC Cominelli F Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis J Clin Invest 94 1 1994 449 453
154. Schwarz T Urbanski A Gschnait F Luger TA UV-irradiated epidermal cells produce a specific inhibitor of interleukin 1 activity J Immunol 138 5 1987 1457 1463
155. Schwarz T Urbanski A Kirnbauer R Kock A Gschnait F Luger TA Detection of a specific inhibitor of interluekin 1 in sera of UVB-treated mice J Invest Dermatol 91 6 1988 536 540
156. Schwarz T Urbanska A Gshnait F Luger TA Inhibition of the induction of contact hypersensitivity by a UV-mediated epidermal cytokine J Invest Dermatol 87 2 1986 289 291
157. Griffiths CE Barker JN Kunkel S Nickoloff BJ Modulation of leukocyte adhesion molecules, a T-cell chemotaxin (IL-8) and a regulatory cytokine (TNF-α) in allergic contact dermatitis (rhus dermatitis) Br J Dermatol 124 6 1991 519 526
158. Koch F Heufler C Kampgen E Schneeweiss D Bock G Schuler G Tumor necrosis factor alpha maintains the viability of murine epidermal Langerhans' cells in culture, but in contrast to granulocyte/macrophage colony-stimulating factor, without inducing their functional maturation J Exp Med 171 1990 159 171
159. Cumberbatch M Kimber I Dermal tumor necrosis factor-α induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans cell migration Immunology 75 1992 257 263
160. van Overveld FJ Jorens PG Rampart M de Backer W Vermeire PA Tumour necrosis factor stimulates human skin mast cells to release histamine and tryptase Clin Exp Allergy 21 6 1991 711 714
161. Bussolino F Arese M Silvestro L Soldi R Benfenati E Sanavio F Involvement of a serine protease in the synthesis of platelet-activating factor by endothelial cells stimulated by tumor necrosis factor-α or interleukin-1α Eur J Immunol 24 12 1994 3131 3139
162. Kuijpers TW Hakkert BC Hart MH Roos D Neutrophil migration across monolayers of cytokine-prestimulated endothelial cells: a role for platelet activating factor and IL-8 J Cell Biol 117 3 1992 565 572
163. Kurimoto I Streilein JW Cis -urocanic acid suppression of contact hypersensitivity induction is mediated via tumor necrosis factor α J Immunol 148 1992 3072 3078
164. Suppl Streilein JW Sunlight and skin-associated lymphoid tissues (SALT): if UVB is the trigger and TNF alpha is its mediator, what is the message? J Invest Dermatol 100 1993 47S 52S
165. Simon JC Edelbaum D Bergstresser PR Cruz PD Jr Distorted antigen-presenting function of Langerhans' cells induced by tumor necrosis factor α via a mechanism that appears different from that induced by ultraviolet B radiation Photodermatol Photoimmunol Photomed 8 5 1991 190 194
166. Piguet PF Grau GE Hauser C Vassalli P Tumor necrosis factor is a critical mediator in hapten-induced irritant and contact hypersensitivity reactions J Exp Med 173 3 1991 673 679
167. Bromberg JS Chavin KD Kunket SL Anti-tumor necrosis factor antibodies suppress cell-mediated immunity in vivo J Immunol 148 1992 3412 3417
168. Jacob CO Tumor necrosis factor α in autoimmunity: pretty girl or old witch? Immunol Today 13 1992 122 125
169. Li P Allen H Bannerjee S Franklin S Herzog L Johnston C Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock Cell 80 3 1995 401 411
170. Mosmann TR Cytokines, differentiation and functions of subsets of CD4 and CD8T cells Behring Inst Mitt 96 1995 1 6
171. Larsen CG Anderson AO Oppenheim JJ Matsushima K Production of IL-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor Immunology 68 1 1989 31 36
172. Baggiolini M Dewald B Moser B Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines Adv Immunol 55 1994 97 179
173. Enk AH Angeloni VL Udey MC Katz SI Inhibition of Langerhans' cell antigen-presenting function by IL-10: a role for IL-10 in induction of tolerance J Immunol 151 5 1993 2390 2398
174. Kaplan G Luster AD Hancock G Cohn ZA The expression of a gamma interferon-induced protein (IP-10) in delayed immune responses in human skin J Exp Med 166 4 1987 1098 1108
175. Bloom BR Bennett B Mechanism of a reaction in vitro associated with delayed hypersensitivity Science 153 1966 80 82
176. Witmer-Pack MD Olivier W Valinsky J Schuler G Steinman RM Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans' cells J Exp Med 166 5 1987 1484 1498
177. Steinman RM Cytokines amplify the function of accessory cells Immunol Lett 17 1988 197 202
178. Caux C Dezutter-Dambuyant C Schmitt D Banchereau J GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans' cells Nature 360 6401 1992 258 261
179. Collins T Korman AJ Wake CT Boss JM Kappes DJ Fiers W Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts Proc Natl Acad Sci USA 81 1984 4917 4921 15
180. Masuyama J Minato N Kano S Mechanisms of lymphocyte adhesion on human vascular endothelial cells in culture J Clin Invest 77 1986 1596 1605
181. Berman B Duncan MR Smith B Ziboh VA Palladino M Interferon enhancement of HLA-DR antigen expression on epidermal Langerhans' cells J Invest Dermatol 84 1 1985 54 58
182. Nickoloff BJ Griffiths CE Barker JN The role of adhesion molecules, chemotactic factors, and cytokines in inflammatory and neoplastic skin disease—1990 update (Review) J Invest Dermatol 94 6 Suppl 1990 151S 157S
183. Belsito DV Epstein SP Schultz JM Baer RL Thorbecke GJ Enhancement by various cytokines or 2-β-mercaptoethanol of Ia antigen expression on Langerhans' cells in skin from normal aged and young mice. Effect of cyclosporine A J Immunol 143 5 1989 1530 1536
184. Marcinkiewicz J Chain B Antigen-specific inhibition of IL-2 and IL-3 production in contact sensitivity to TNP Immunology 68 1989 185 189
185. Kimber I Cumberbatch M Humphreys M Hopkins SJ Contact hypersensitivity induces plasma inteleukin 6 Int Arch Allergy Appl Immunol 92 1 1990 97 99
186. Oxholm A Oxholm P Avnstorp C Bendtzen K Keratinocyte-expression of interleukin-6 but not of tumour necrosis factor-alpha is increased in the allergic and the irritant patch test reaction Acta Derm Venereol (Stockh) 71 2 1991 93 98
187. Mihara M Ikuta M Koishihara Y Ohsugi Y Interleukin 6 inhibits delayed-type hypersensitivity and the development of adjuvant arthritis Eur J Immunol 21 10 1991 2327 2331
188. Kimber I Cumberbatch M Dendritic cells and cutaneous immune responses to chemical allergens Toxicol Appl Pharmacol 117 1992 137 146
189. Ferguson TA Dube P Griffith TS Regulation of contact hypersensitivity by interleukin 10 J Exp Med 179 1994 1597 1604
190. Schwarz A Grabbe S Riemann H Aragane Y Simon M Manon S In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions J Invest Dermatol 103 2 1994 211 216
191. Ralph P Nakoinz I Sampson-Johannes A Fong S Lowe D Min HY Lin L IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor J Immunol 148 3 1992 808 814
192. Jenkins JK Malyak M Arend WP The effects of IL-10 on interleukin-1 receptor antagonist and IL-1β production in human monocytes and neutrophils Lymphokine Cytokine Res 13 1994 47 54
193. Enk AH Saloga J Becker D Mohamadzadeh M Knop J Induction of hapten-specific tolerance by interleukin-10 in vivo J Exp Med 179 4 1994 1397 1402
194. a. Kupper TS Cytokines in pathophysiologic responses in skin: recruitment of inflammatory infiltrates to cutaneous tissues Oppenheim JJ Rossio JL Gearing AJH Clinical applications of cytokines: role in pathogenesis, diagnosis and therapy 1993 Oxford University Press New York 251 255
195. b. Muller G Saloga J Germann T Bellinghausen I Mohamadzadeh M Knop J Identification and induction of human keratinocyte-derived IL-12 J Clin Invest 94 5 1994 1799 1805
196. Muller G Saloga J Germann T Schuler G Knop J Enk AH IL-12 as mediator and adjuvant for the induction of contact sensitivity in vivo J Immunol 155 10 1995 4661 4668
197. Epstein SP Baer RL Thorbecke GJ Belsito DV Immunosuppressive effects of transforming growth factor β: inhibition of the induction of Ia antigen on Langerhans' cells by cytokines and of the contact hypersensitivity response J Invest Dermatol 96 6 1991 832 837
198. Wahl SM Transforming growth factor β: the good, the bad, and the ugly J Exp Med 180 1994 1587 1590
199. Rheins LA Cotleur AL Kleier RS Hoppenjans WB Sauder DN Nordlund JJ Alpha-melanocyte stimulating hormone modulates contact hypersensitivity responsiveness in C57/BL6 mice J Invest Dermatol 93 4 1989 511 517
200. Weihe E Hartschuh W Multiple peptides in cutaneous nerves: regulators under physiologic conditions and a pathogenetic role in skin diseases? Semin Dermatol 7 1988 284 300
201. Girolomoni G Tigelaar RE Capsaicin-sensitive primary sensory neurons are potent modulators of murine delayed-type hypersensitivity reactions J Immunol 45 1990 1105 1112
202. Hosoi J Murphy GF Egan CL Lerner EA Grabbe S Asahina A Regulation of Langerhans' cell function by nerves containing calcitonin gene-related peptide Nature 363 6425 1993 159 163
203. Asahina A Hosoi J Beissert S Stratigos A Granstein RD Inhibition of the induction of delayed-type and contact hypersensitivity by calcitonin gene-related peptide J Immunol 154 7 1995 3056 3061
204. Girolomoni G Tigelaar RE Peptidergic neurons and vasoactive intestinal peptide modulate experimental delayed-type hypersensitivity reactions Ann NY Acad Sci 650 1992 9 12
205. Goebeler M Henseleit U Roth J Sorg C Substance P and calcitonin gene-related peptide modulate leukocyte infiltration to mouse skin during allergic contact dermatitis Arch Dermatol Res 286 6 1994 341 346
206. Di Marco E Marchisio PC Bondanza S Franzi AT Cancedda R De Luca M Growth-regulated synthesis and secretion of biologically active nerve growth factor by human keratinocytes J Biol Chem 266 32 1991 21718 21722
207. Leon A Buriani A Dal Toso R Fabris M Romanello S Aloe L Mast cells synthesize, store, and release nerve growth factor Proc Natl Acad Sci USA 91 1994 3739 3743 9
208. Donnerer J Schuligoi R Stein C Amann R Upregulation, release and axonal transport of substance P and calcitonin gene-related peptide in adjuvant inflammation and regulatory function of nerve growth factor (Review) Regul Pept 46 1993 150 154
209. Creamer JD Barker JNWN Vascular proliferation and angiogenic factors in psoriasis Clin Exp Dermatol 20 1995 6 9
210. Yoshinaga Y Higaki M Terajima S Ohkubo E Nogita T Miyasaka N Detection of inflammatory cytokines in psoriatic skin Arch Dermatol Res 287 2 1995 158 164
211. Olaniran AK Baker BS Garioch JJ Powles AV Fry L A comparison of the stimulatory effects of cytokines on normal and psoriatic keratinocytes in vitro Arch Dermatol Res 287 3–4 1995 231 236
212. Prens EP van Joost T Hegmans JP 'tHooft-Benne K Ysselmuiden OE Benner R Effects of cyclosporine on cytokines and cytokine receptors in psoriasis J Am Acad Dermatol 33 6 1995 947 953
213. Elder JT Cytokine and genetic regulation of psoriasis Adv Dermatol 10 1995 99 133
214. Fantini F Magnoni C Bracci-Laudiero L Pincelli C Nerve growth factor is increased in psoriatic skin J Invest Dermatol 105 6 1995 854 855
215. Kupper TS Immune and inflammatory processes in cutaneous tissues J Clin Invest 86 1991 1783 1789
216. 1 J Immunol 144 12 1990 4593 4603
217. Uyemura K Yamamura M Fivenson DF Modlin RL Nickoloff BJ The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response J Invest Dermatol 101 5 1993 701 705
218. Kojima T Ho C Voorhees JJ Cyclosporin A reduced Th1-type T cell cytokine expression is psoriasis prior to clinical improvement [abstract] J Invest Dermatol 100 1993 572A
219. a. Lee RE Gaspari AA Lotze MT Chang AE Rosenberg SA Interleukin 2 and psoriasis Arch Dermatol 124 12 1988 1811 1815
220. b. Kahaleh MB LeRoy EC Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration Ann Intern Med 110 1989 446 450
221. Kapp A Piskorski A Schopf E Elevated levels of interleukin 2 receptor in sera of patients with atopic dermatitis and psoriasis Br J Dermatol 119 1988 707 710
222. Takematsu H Tagami H Interleukin 2, soluble interleukin 2 receptor, and interferon-gamma in the suction blister fluids from psoriatic skin [comments] Arch Dermatol Res 282 1990 149 152
223. Takematsu H Tagami H Granulocyte-macrophage colony-stimulating factor in psoriasis Dermatologica 181 1990 16 20
224. Elder JT Sartor CI Boman DK Benrazavi S Fisher GJ Interleukin-6 in psoriasis:expression and mitogenicity studies Arch Dermatol Res 284 6 1992 324 332
225. Krane JF Gottlieb AB Carter DM Krueger JG The insulin-like growth factor I receptor is overexpressed in psoriatic epidermis, but is differentially regulated from the epidermal growth factor receptor J Exp Med 175 4 1992 1081 1090
226. Yaguchi H Tsuboi R Ueki R Ogawa H Immunohistochemical localization of basic fibroblast growth factor in skin diseases Acta Derm Venereol 73 2 1993 81 83
227. Krane JF Murphy DP Gottlieb AB Carter DM Hart CE Krueger JG Increased dermal expression of platelet-derived growth factor receptors in growth-activated skin wounds and psoriasis J Invest Dermatol 96 6 1991 983 986
228. Elder JT Ellingsworth LR Fisher GJ Voorhees JJ Transforming growth factor-beta in psoriasis: pathogenesis and therapy Ann N Y Acad Sci 593 1990 218 230
229. Elder JT Fisher GJ Lindquist PB Bennett GL Pittelkow MR Coffey RJ Overexpression of transforming growth factor alpha in psoriatic epidermis Science 243 4892 1989 811 814
230. Schreiber AB Winkler ME Derynck R Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor Science 232 1986 1250 1253
231. Grossman RM Krueger J Yourish D Granelli-Piperno A Murphy DP May LT Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes Proc Natl Acad Sci USA 86 1989 6367 6371 16
232. Toruniowa B Krasowska D Koziol M Ksiazek A Pietrzak A Serum levels of IL-6 in mycosis fungoides, psoriasis, and lichen planus Ann N Y Acad Sci 762 1995 432 434
233. Gearing AJ Fincham NJ Bird CR Wadhwa M Meager A Cartwright JE Cytokines in skin lesions of psoriasis Cytokine 2 1 1990 68 75
234. Fagundus DM LeRoy EC Cytokines and systemic sclerosis Clin Dermatol 12 1994 407 417
235. Frieri M Agarwal K Mast cell effects on cytokine production in scleroderma patients J Allergy Clin Immunol 87 1991 86a
236. Frieri M Systemic sclerosis: the role of the mast cell and cytokines Ann Allergy 69 1992 385 396
237. Kahaleh MB Soluble immunologic products in scleroderma sera Clin Immunol Immunopathol 58 1991 139 144
238. Hawrylko E Spertus A Mele CA Oster N Frieri M Increased interleukin-2 production in response to human type I collagen stimulation in patients with systemic sclerosis Arthritis Rheum 34 5 1991 580 587
239. Umehara H Kumagai S Ishida H Suginoshita T Maeda M Imura H Enhanced production of interleukin-2 in patients with progressive systemic sclerosis. Hyperactivity of CD4-positive T cells Arthritis Rheum 31 3 1988 401 407
240. Degiannis D Seibold JR Czarnecki M Soluble interleukin-2 receptors in patients with systemic sclerosis Arthritis Rheum 33 1990 375 380
241. Clements PJ Peter JB Agopian MS Elevated serum levels of soluble interleukin 2 receptor, interleukin 2 and neopterin in diffuse and limited scleroderma: effect of chlorambucil J Rheumatol 17 1990 908 910
242. Mizel SB Interleukin 1 and T cell activation Immunol Rev 63 1982 51 72
243. Alocer-Varela J Martinez-Cordero E Alarcon-Segovia D Spontaneous production of, and defective response to, interleukin-1 by peripheral blood mononuclear cells from patients and scleroderma Clin Exp Immunol 59 1985 666 672
244. Frieri M Angadi C Paolano A Immunoregulatory defects in scleroderma J Allergy Clin Immunol 81 1988 196a
245. Needleman BW Wigley FM Stair RW Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor α, and interferon-γ levels in sera from patients with scleroderma Arthritis Rheum 35 1992 67 72
246. Gurram M Pahwa S Frieri M Interleukin-6 levels in collagen-stimulated peripheral blood mononuclear cells from systemic sclerosis patients [abstract] J Allergy Clin Immunol 89s 1992 291
247. Takemura H Suzuki H Yoshizaki K Ogata A Yuhara T Akama T Anti-interleukin-6 autoantibodies in rheumatic disease. Increased frequency in the sera of patients with systemic sclerosis Arthritis Rheum 35 8 1992 940 943
248. Feghali CA Bost KL Boulware DW Levy LS Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin-6 by fibroblasts cultured from affected skin sites of patients with scleroderma J Rheumatol 19 8 1992 1207 1211
249. Duncan MR Berman B Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6 J Invest Dermatol 97 1991 686 692
250. Kahaleh MB Yin T Enhanced expression of high-affinity interleukin-2 receptors in scleroderma: possible role for IL-6 Clin Immunol Immunopathol 62 1992 97 102
251. Claman HN On scleroderma mast cells, endothelial cells and fibroblasts JAMA 262 1982 1206 1209
252. Gajdusek C Release of endothelial cell-derived growth factor (ECDGF) by heparin J Cell Physiol 121 1984 12 21
253. Needleman BW Choi J Burrows-Mezu A Fontana JA Secretion and binding of transforming growth factor β by scleroderma and normal dermal fibroblasts Arthritis Rheum 33 5 1990 650 656
254. Gruschwitz M Muller PU Sepp N Hofer E Fontana A Wick G Transcription and expression of transforming growth factor type beta in the skin of progressive systemic sclerosis: a mediator of fibrosis? J Invest Dermatol 94 2 1990 197 203
255. LeRoy EC Smith EA Kahaleh MB A strategy for determining the pathogenesis of systemic sclerosis: is transforming growth factor β the answer? Arthritis Rheum 32 1989 817 825
256. Peltonen L Palotie A Myllyla R Krieg T Oikarinen A Collagen biosynthesis in systemic scleroderma: regulation of post-translational modifications and synthesis of procollagen in cultured fibroblasts J Invest Dermatol 84 1 1985 14 18
257. Ignotz RA Endo T Massague J Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-β J Biol Chem 262 1987 6443 6446
258. Raghow R Postlethwaite AE Keski-Oja J Moses HL Kang AH Transforming growth factor-β increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts J Clin Invest 79 4 1987 1285 1288
259. 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea J Rheumatol 18 2 1991 247 251
260. Kahaleh MB Osburn I LeRoy EC Elevated levels of circulating platelet aggregates and beta-thromboglobulin in scleroderma Ann Intern Med 9 1982 610 613
261. Moreland LW Huang G-Q Gay RE Jones RE Jr Blackburn WD Jr Alarcon GS Immunohistologic demonstration of platelet-derived growth factor and fibroblast growth factor in scleroderma skin Arthritis Rheum 33 9 1990 S36
262. 1 on human fibroblasts involved the induction of platelet-derived growth factor α receptors J Cell Physiol 145 1990 181 186
263. Moreland LW Huang G Gay R Immunohistologic demonstration of platelet-derived growth factor (PDGF) and fibroblast growth factor (FGF) in scleroderma (SCL) skin [abstract] Arthritis Rheum 33 1990 S36
264. Gay S Boulware DW Gay RE Oncogenes, growth factors and matrix in pathogenesis of systemic sclerosis Clin Dermatol 12 1994 419 424
265. Kupper TS Edelson RL The role of cytokines in the pathophysiology of T cell mediated skin disease J Dermatol 14 1987 517 523
266. Wahlgren CF Tengvall Linder M Hagermark O Scheynius A Itch and inflammation induced by intradermally injected interleukin-2 in atopic dermatitis patients and healthy subjects Arch Dermatol Res 287 6 1995 517 523
267. Modlin RL Cytokines responses in leprosy lesions Nippon Rai Gakkai Zasshi [Japanese Journal of Leprosy] 64 1995 85 88
268. Yamamura M Uyemura K Deans RJ Weinberg K Rea TH Bloom BR Defining protective responses to pathogens: cytokine profiles in leprosy lesions Science 254 5029 1991 277 279
269. Johansson O Nordlind K Efendic S Liden S The immunohistochemical observation of somatostatin-like and avian pancreatic polypeptide-like immunoreactivity in certain cellular elements of diabetic lipodystrophic skin Dermatologica 171 1985 233 237
270. Johansson O Vaalasti A Immunohistochemical evidence for the presence of somatostatin-containing sensory nerve fibers in human skin Neurosci Lett 73 1987 225 230
271. Johansson O Morphologic characterization of the somatostatin-immunoreactive dendritic skin cells in urticaria pigmentosa by patients in computerized image analysis Scand J Immunol 21 1985 431 439
272. Johannson O Nordlind K Immunohistochemical localization of somatostatin-like immunoreactivity in skin lesions from patients with urticaria pigmentosa Virchows Arch B 46 1984 155 164
273. Elsborg L Glenthoj A Effect of somatostatin in necrolytic migratory erythema of glucagonoma Acta Med Scand 218 1985 245 249
274. Wallengren J Ekman R Molser H Substance P and vasoactive intestinal peptide in bullous and inflammatory skin disease Acta Derm Venereol 66 1986 23 28
275. Berman B Duncan MR Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitro J Am Acad Dermatol 21 1989 694 702
276. Tulli A Capizzi G Petitti G Interferons in scleroderma: clinical use [abstract] J Invest Dermatol 93 1989 582
277. Fierlbeck G Behçet's disease: therapy with recombinant interferon gamma (Letter)(in German) Dtsch Med Wochenschr 114 45 1989 1769
278. Musial J Milewski M Undas A Kopinski P Duplaga M Szczeklik A Interferon-gamma in the treatment of atopic dermatitis: influence on T-cell activation Allergy 50 6 1995 520 523
279. Reinhold U Wehrmann W Kukel S Recombinant interferon-γ in severe atopic dermatitis [letter] Lancet 1 1990 1282
280. MacKie RM Interferon-α for atopic dermatitis Lancet 1 1990 1282 1283
281. Heaney ML Golde DW Soluble cytokine receptors Blood 87 3 1996 847 857
282. Piguet PF Vesin C Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice Eur Respir J 7 1994 427 428
283. Zinkel S Fuchs E Skin cancer and transgenic mice Semin Cancer Biol 5 1994 77 90